Filing Details
UNITED THERAPEUTICS Corp (NASDAQ:UTHR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 04, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:UTHR
UNITED THERAPEUTICS Corp (UTHR) Files Quarterly Report for Q0
UNITED THERAPEUTICS Corp (NASDAQ:UTHR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 04, 2026.
At publication ·
What changed
UNITED THERAPEUTICS Corp (NASDAQ:UTHR) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- United Therapeutics Corp filed its Q0 2026 quarterly report (Form 10-Q) on November 04, 2026 with the Securities and Exchange Commission.
- The company's stock trades at $601.32 with a market capitalization of $21.8 billion.
- The 10-Q filing includes unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
UNITED THERAPEUTICS Corp's stock currently trades at $601.32 with a market capitalization of $21.8B.
The 10-Q provides UNITED THERAPEUTICS Corp's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for UNITED THERAPEUTICS Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View UTHR Stock Page
Frequently Asked Questions
Where can I read UTHR's SEC filings?
Browse all filings on our UTHR SEC filings page.
What types of SEC filings does UNITED THERAPEUTICS Corp file?
Public companies like UNITED THERAPEUTICS Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.